Abstract
COVID-19 gastrointestinal manifestations could be attributed to SARS-CoV-2-induced small vessel thrombosis. OA with NPT treatment may have a role in optimization of bowel microcirculation and in the reduction of the endothelial and the systemic cytokine-related damage, improving also respiratory function.
Introduction
Since the beginning of the SARS-CoV-2 outbreak, alongside the most common clinical manifestations such as fever, cough and dyspnea, other clinical presentations have been described [1]. It has been shown that the virus can affect the GI tract and all other possible organs and tissues [2], [3], [4], [5].
This could be linked to the presence of the viral receptor of the angiotensin-converting enzyme 2 (ACE2), into host cells of different tissues, including the GI tract [6], [7]. Moreover, several studies demonstrated the presence of SARS-CoV-2 RNA in rectal swabs and stool specimens [8], [9]. Indeed, also gastrointestinal manifestations such as abdominal pain, vomiting and diarrhea have been reported [10].
Gastrointestinal manifestations could be attributed to pharmacologic effects, metabolic disorders encountered in ICU patients, other opportunistic colonic pathogens, COVID-19 related “viral enteropathy” but also SARS-CoV-2-induced small vessels thrombosis is a possible pathophysiological hypothesis [11], [12].
During this pandemic, we managed several COVID-19 patients presenting with gastrointestinal manifestations, such as colitis (11 patients), bowel perforation (3 patients) and ischaemia (3 patients).
Some of these patients underwent an OA treatment for surgical complications - eg. abdominal compartimental syndrome (ACS) – and showed a rapid improvement of both respiratory and gut disfunction.
Our hypothesis is that OA may have a pivotal role in improving bowel microcirculation reducing the endothelial and the systemic cytokine-related damage in COVID19 patient.
Hypothesis.
The involvement of multiples organs with different severity of clinical manifestations has led several authors to propose that the main damage is not primarily in the pulmonary parenchyma, but at the level of the microcirculation. Therefore, a target therapy, aimed at improving the capillary vascularization, for example low molecular weight heparin, can lead to a substantial improvement of these patients [11], [13]. According to Klok et al among 184 COVID-19 patients in a Dutch ICU, 38% had coagulation abnormalities and almost one-third already had clots [14]. In the light of these data, it has been assumed that COVID-19 targets blood vessels and all clinical manifestations start from this type of damage. This is also confirmed by the paradigm brought to attention from many ICU physician that even if SARS-COV-2 patient have a normal or even higher lung compliance, oxygen uptake is altered by constricted blood vessels rather than by clogged alveoli.
In early March, Carvalho et al reported the first case of SARS-CoV-2 gastrointestinal infection causing haemorrhagic colitis that has spontaneously improved by targeted COVID-19 therapy [15].
Bhayana et al. reported radiological vascular abnormalities of a COVID19 patient series, often seen in patients with intestinal ischaemia, such as bowel wall thickening, pneumatosis and portal venous gas [16].
Since the beginning of the SARS-CoV-2 outbreak, the Fondazione Policlinico Universitario A. Gemelli IRCCS (FPG) hospital of Rome has been identified as both medical and surgical hub for COVID19. Among 3200 admissions for suspected COVID-19, there were 682 confirmed patients. We performed 82 surgical consultations (32 for COVID19 positive patients and 54 for suspected ones). Three of them suffered from megacolon and intestinal pneumatosis. These patients, due to suspected intestinal ischaemia with or without ACS, underwent surgical intervention and benefited of an OA and NPT without intestinal resections.
In our cases, the prompt reduction of the intra-abdominal pressure (IAP) with OA led to a quick improvement of the colonic alteration but also of the respiratory function.
According to the last WSES guidelines, the use of OA should be considered after perfusion restoration in patients with acute mesenteric ischaemia (occlusive and/or non-occlusive) in case of deranged physiology and bowel oedema and/or necessity to perform a second look or a delayed anastomosis [17]. Moreover, it has been suggested by some studies that inflammatory mediators such as cytokines released during intestinal ischaemia-reperfusion damage, increase permeability in the lungs with subsequent pulmonary injury. In the light of this, the control of local cytokines production in the peritoneal cavity may be important in order to prevent worsening of lung failure as well as of all the other organs [18], [19].
Based on this concepts, even if just anecdotal, our cases show that as first OA can improve the arterial and venous blood flow in the gastrointestinal tract by reducing IAP. Moreover, NPT allows cytokine clearance leading to a reduction of vascular endothelial damage. Both of these mechanisms might potentially improve microcirculation conditions determining an optimization of systemic perfusion and organ function.
Of course, further studies are needed in order to confirm this possible pathophysiological hypothesis.
Competing interest
The authors declare no potential financial conflict of interest related to this manuscript.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Availability of data and material
'Not applicable'.
Code availability
'Not applicable'.
Author contributions
MDG, PF: Study conception and design, literature search, acquisition, interpretation and analysis of data; drafting and critically revising the article for important intellectual content; and final approval of the version to be published. FS: literature search, acquisition, interpretation and analysis of data. FT, VF, PM: Interpretation and analysis of data. VC ALG: Interpretation and analysis of data; drafting and critically revising the article for important intellectual content; and final approval of the version to be published. GS: critically revising the article for important intellectual content; and final approval of the version to be published.
References
- 1.Gu J., Han B., Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020;158(6):1518–1519. doi: 10.1053/j.gastro.2020.02.054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Madjid M., Safavi-Naeini P., Solomon S.D., Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020 doi: 10.1001/jamacardio.2020.1286. [DOI] [PubMed] [Google Scholar]
- 3.Tammaro A., Adebanjo G.A.R., Parisella F.R., Pezzuto A., Rello J. Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome. J Eur Acad Dermatol Venereol. 2020 doi: 10.1111/jdv.16530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Ye M., Ren Y., Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immun. 2020 doi: 10.1016/j.bbi.2020.04.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Shi S., Qin M., Shen B., Cai Y., Liu T., Yang F. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan. China. JAMA Cardiol. 2020 doi: 10.1001/jamacardio.2020.0950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Xiao F., Tang M., Zheng X., Liu Y., Li X., Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831–1833. doi: 10.1053/j.gastro.2020.02.055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Harmer D., Gilbert M., Borman R., Clark K.L. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 2002;532(1–2):107–110. doi: 10.1016/s0014-5793(02)03640-2. [DOI] [PubMed] [Google Scholar]
- 8.Zhang W., Du R.H., Li B., Zheng X.S., Yang X.L., Hu B. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):386–389. doi: 10.1080/22221751.2020.1729071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Young B.E., Ong S.W.X., Kalimuddin S., Low J.G., Tan S.Y., Loh J. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020 doi: 10.1001/jama.2020.3204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Connors J.M., Levy J.H. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost. 2020 doi: 10.1111/jth.14849. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Wells C.I., O'Grady G., Bissett I.P. Acute colonic pseudo-obstruction: a systematic review of aetiology and mechanisms. World J Gastroenterol. 2017;23(30):5634–5644. doi: 10.3748/wjg.v23.i30.5634. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Panigada M., Bottino N., Tagliabue P., Grasselli G., Novembrino C., Chantarangkul V. Hypercoagulability of COVID-19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis. J Thromb Haemost. 2020 doi: 10.1111/jth.14850. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Klok F.A., Kruip M.J.H.A., van der Meer N.J.M., Arbous M.S., Gommers D.A.M.P.J., Kant K.M. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020 doi: 10.1016/j.thromres.2020.04.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Carvalho A., Alqusairi R., Adams A., Paul M., Kothari N., Peters S. SARS-CoV-2 gastrointestinal infection causing hemorrhagic colitis: implications for detection and transmission of COVID-19 disease. Am J Gastroenterol. 2020 doi: 10.14309/ajg.0000000000000667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Bhayana R., Som A., Li M.D., Carey D.E., Anderson M.A., Blake M.A. Abdominal imaging findings in COVID-19: preliminary observations. Radiology. 2020 doi: 10.1148/radiol.2020201908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Coccolini F., Roberts D., Ansaloni L., Ivatury R., Gamberini E., Kluger Y. The open abdomen in trauma and non-trauma patients: WSES guidelines. World J Emerg Surg. 2018;13:7. doi: 10.1186/s13017-018-0167-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Sganga G. From infection to sepsis and organ(s) dysfunction. The surgical point of view. Minerva Anestesiol. 2001;67(1-2):7–22. [PubMed] [Google Scholar]
- 19.Rossi M., Sganga G., Mazzone M., Valenza V. Cardiopulmonary bypass in man: role of the intestine in a self-limiting inflammatory response with demonstrable bacterial translocation. Ann Thorac Surg. 2004;77(2):612–618. doi: 10.1016/S0003-4975(03)01520-0. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
'Not applicable'.